Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genital Herpes Simplex Type 2”

36 trials

Showing 20 of 36 results

Testing effectiveness (Phase 2)Study completedNCT01667341
What this trial is testing

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 143
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Large-scale testing (Phase 3)Study completedNCT00194519
What this trial is testing

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Who this might be right for
HIV InfectionHerpes Simplex, GenitalSexually Transmitted Diseases
University of Washington 3,408
Post-approval studies (Phase 4)Study completedNCT00464542
What this trial is testing

Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study

Who this might be right for
Bacterial Vaginosis
University of Pittsburgh 12
Testing effectiveness (Phase 2)Study completedNCT02515175
What this trial is testing

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 131
Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Testing effectiveness (Phase 2)Study completedNCT02837575
What this trial is testing

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

Who this might be right for
Herpes Genitalis
Vical 261
Not applicableStudy completedNCT00946556
What this trial is testing

Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix

Who this might be right for
Herpes Simplex Type Two InfectionHIV Infections
University of Toronto 30
Not applicableStudy completedNCT03090802
What this trial is testing

MAMAS: Mentoring Adolescent Mothers at School

Who this might be right for
Human Immunodeficiency VirusHerpes Simplex Type IIChlamydia+2 more
Drexel University 152
Not applicableWithdrawnNCT04294030
What this trial is testing

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
HSV-2 InfectionHerpes Simplex Virus Infection
NOWDiagnostics, Inc.
Not applicableStudy completedNCT01460433
What this trial is testing

Problems With Immune Recovery in the Gut Tissue

Who this might be right for
Human Immunodeficiency Virus
University of Minnesota 21
Early research (Phase 1)Active Not RecruitingNCT05432583
What this trial is testing

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Who this might be right for
Genital Herpes Simplex Type 2
BioNTech SE 318
Large-scale testing (Phase 3)Study completedNCT00860977
What this trial is testing

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Who this might be right for
HIV InfectionHerpes Simplex Type IIHIV Infections
University Health Network, Toronto 202
Not applicableStudy completedNCT02910284
What this trial is testing

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 140
Early research (Phase 1)Study completedNCT06385327
What this trial is testing

Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 115
Not applicableWithdrawnNCT00682721
What this trial is testing

Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women

Who this might be right for
Bacterial VaginosisHerpes Simplex Virus Type II
University of Pittsburgh
Post-approval studies (Phase 4)Study completedNCT00527618
What this trial is testing

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

Who this might be right for
Genital HerpesHIV Infection
University of Washington 28
Post-approval studies (Phase 4)Study completedNCT00362297
What this trial is testing

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Who this might be right for
Genital Herpes
University of Washington 31
Early research (Phase 1)Study completedNCT06698575
What this trial is testing

Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 103
Testing effectiveness (Phase 2)Study completedNCT01047540
What this trial is testing

Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2

Who this might be right for
HSV-2
AiCuris Anti-infective Cures AG 156
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation